MET and neoplasm: After a durable clinical and radiographic response, the progression biopsy demonstrated loss of MET amplification together with emergent HGF p.G401A and NF1 p.M546L, pointing to ligand reactivation and RAS/MAPK bypass as hypothesis-generating routes of escape in this tumor.